Sponsor or institution
Clinical trials and research at K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
As of November 12, 2026, Find a Trial lists 3 clinical trials run by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc that are recruiting, at sites in 26 countries (most in Australia (3), France (3), South Korea (3)). By phase: Phase 1 (1), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 26Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Azenosertib plus chemotherapy vs physician’s choice in cyclin E1–positive platinum-resistant high-grade ovarian, fallopian tube, or primary peritoneal cancer | Phase 3 | Phoenix, Arizona and 128 other locations | Recruiting | Apr 22, 2026 |
| Evaluating azenosertib for treating platinum-resistant ovarian cancer | Phase 2 | Mobile, Alabama and 88 other locations | Recruiting | Nov 22, 2021 |
| Evaluating ZN-c3 for patients with ovarian cancer | Phase 1 | Aurora, Colorado and 34 other locations | Recruiting | Aug 18, 2020 |
All recruiting trials (3)
-
Azenosertib plus chemotherapy vs physician’s choice in cyclin E1–positive platinum-resistant high-grade ovarian, fallopian tube, or primary peritoneal cancer
This trial tests whether taking the drug azenosertib along with the doctor’s chosen chemotherapy helps patients with platinum-resistant cyclin E1–positive ovarian cancer.
-
Evaluating azenosertib for treating platinum-resistant ovarian cancer
This study is testing a new drug called azenosertib to see if it can help people with platinum-resistant ovarian cancer feel better and improve their treatment outcomes.
-
Evaluating ZN-c3 for patients with ovarian cancer
This study is testing a new treatment called ZN-c3 combined with other chemotherapy drugs to see if it is safe and effective for people with advanced ovarian cancer.
Quick answers
How many clinical trials run by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 26 countries. The most sites are in Australia (3 trials), France (3 trials), South Korea (3 trials), United States (3 trials), Belgium (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.